CBRE and its Trammell Crow subsidiary are planning their first ground-up biotech lab development in San Diego, joining numerous other nationwide developers seeking to capitalize on escalating demand for life science real estate.
CBRE and its Trammell Crow subsidiary are planning their first ground-up biotech lab development in San Diego, joining numerous other nationwide developers seeking to capitalize on escalating demand for life science real estate.
Watch the video to learn how you can access industry leading CRE news and the data analytics you need to drive success.
This news story is available exclusively to CoStar subscribers.
Ready to Learn More?
Sign Up For a Personalized Demo.
Sign Up For a Demo To Learn More.
Already A Subscriber? Sign In
Real Estate
Real Estate
Real Estate
Senior Managing Director & Portfolio Manager, CBRE Investment Management